title: Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis.
abstract: Occult hepatitis B infection (OBI) is defined as long-lasting persistence of hepatitis B virus (HBV) DNA in the liver of patients with hepatitis B surface antigen (HBsAg)-negative status, with or without serological markers of previous exposure (antibodies to HBsAg and/or to hepatitis B core antigen). Over the past two decades, significant progress has been made in understanding OBI and its clinical implications. OBI as a cause of chronic liver disease in patients with HBsAg-negative status is becoming an important disease entity. In conditions of immunocompetence, OBI is inoffensive in itself and detection of HBV DNA in the liver does not always indicate active hepatitis. However, when other factors that cause liver damage, such as hepatitis C virus infection, obesity and alcohol abuse are present, the minimal lesions produced by the immunological response to OBI might worsen the clinical course of the underlying liver disease. Several lines of evidence suggest that OBI is associated with progression of liver fibrosis and the development of hepatocellular carcinoma in patients with chronic liver disease. The major interest in OBI is primarily associated with the growing, widely discussed evidence of its clinical impact. The aim of this review is to highlight recent data for OBI, with a major focus on disease progression or carcinogenesis in patients with chronic liver disease.
authors.affiliation: Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
authors.forename: Hiroki
authors.initials: H
authors.lastname: Nishikawa
authors.forename: Yukio
authors.initials: Y
authors.lastname: Osaki
keywords: carcinogenesis; chronic liver disease; clinical outcome; hepatitis B virus; occult hepatitis B infection
references.citation: Cancer. 2004 Aug 15;101(4):796-802
references.pmid: 15305412
references.citation: Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578
references.pmid: 22158026
references.citation: J Med Virol. 1999 Jul;58(3):201-7
references.pmid: 10447413
references.citation: Anticancer Res. 2013 May;33(5):2211-9
references.pmid: 23645778
references.citation: Cancer. 1999 Sep 1;86(5):793-8
references.pmid: 10463977
references.citation: Hepat Res Treat. 2013;2013:259148
references.pmid: 23533738
references.citation: Ann Surg. 2011 Aug;254(2):326-32
references.pmid: 21709542
references.citation: Hepatol Res. 2013 Nov;43(11):1130-8
references.pmid: 23413835
references.citation: J Infect. 2009 May;58(5):383-8
references.pmid: 19329189
references.citation: Intervirology. 2008;51(5):352-61
references.pmid: 19127078
references.citation: Carcinogenesis. 2012 Jan;33(1):209-19
references.pmid: 22021908
references.citation: Scand J Gastroenterol. 2008;43(7):849-56
references.pmid: 18584524
references.citation: J Hepatol. 1995 Jul;23(1):14-20
references.pmid: 8530804
references.citation: N Engl J Med. 1985 Jan 31;312(5):270-6
references.pmid: 2981408
references.citation: J Hepatol. 2007 Jan;46(1):160-70
references.pmid: 17112622
references.citation: Virol J. 2011 Mar 03;8:90
references.pmid: 21371325
references.citation: J Gastroenterol. 2007 Apr;42(4):298-305
references.pmid: 17464459
references.citation: J Clin Microbiol. 2002 Nov;40(11):4068-71
references.pmid: 12409376
references.citation: J Clin Invest. 1994 Jan;93(1):230-9
references.pmid: 8282792
references.citation: J Hepatol. 2012;56 Suppl 1:S75-87
references.pmid: 22300468
references.citation: Lancet Infect Dis. 2002 Aug;2(8):479-86
references.pmid: 12150847
references.citation: Transfusion. 2012 Aug;52(8):1819-26
references.pmid: 22404554
references.citation: Hepatol Res. 2008 Jun;38(6):546-56
references.pmid: 18179561
references.citation: Gastroenterology. 2004 Jan;126(1):347-50
references.pmid: 14699513
references.citation: Gastroenterology. 2012 May;142(6):1264-1273.e1
references.pmid: 22537432
references.citation: Liver Int. 2005 Apr;25(2):247-53
references.pmid: 15780046
references.citation: Dig Liver Dis. 2013 Mar;45(3):238-44
references.pmid: 23146778
references.citation: J Med Virol. 2008 Sep;80(9):1547-53
references.pmid: 18649338
references.citation: Eur J Cancer. 2010 Aug;46(12):2178-86
references.pmid: 20413301
references.citation: Hepatology. 2001 Nov;34(5):1027-34
references.pmid: 11679975
references.citation: J Gen Virol. 2004 Feb;85(Pt 2):275-282
references.pmid: 14769885
references.citation: Clin Cancer Res. 2005 Aug 15;11(16):5821-6
references.pmid: 16115921
references.citation: Intervirology. 2008;51(1):59-68
references.pmid: 18349544
references.citation: J Hepatol. 2008 Oct;49(4):652-7
references.pmid: 18715666
references.citation: Nature. 1991 May 23;351(6324):317-20
references.pmid: 2034275
references.citation: Hepatology. 1998 May;27(5):1377-82
references.pmid: 9581694
references.citation: Saudi Med J. 2005 Apr;26(4):601-6
references.pmid: 15900369
references.citation: Ann Intern Med. 2007 May 1;146(9):649-56
references.pmid: 17470833
references.citation: Leuk Lymphoma. 2009 Apr;50(4):604-11
references.pmid: 19373659
references.citation: Eur J Cancer Prev. 2013 Jul;22(4):328-34
references.pmid: 23165286
references.citation: Gastroenterology. 2008 May;134(5):1470-81
references.pmid: 18355815
references.citation: Hepatology. 2012 Jan;55(1):108-20
references.pmid: 21932402
references.citation: Eur J Intern Med. 2011 Apr;22(2):187-90
references.pmid: 21402251
references.citation: Hepatology. 2013 Jan;57(1):399-408
references.pmid: 22806323
references.citation: N Engl J Med. 1999 Jul 1;341(1):22-6
references.pmid: 10387938
references.citation: Scand J Surg. 2011;100(1):22-9
references.pmid: 21482502
references.citation: Hepatology. 2001 Jul;34(1):194-203
references.pmid: 11431751
references.citation: Oncol Rep. 2013 Jul;30(1):91-8
references.pmid: 23615658
references.citation: Int J Oncol. 2013 Jan;42(1):151-60
references.pmid: 23174998
references.citation: Cancer. 2006 Mar 15;106(6):1326-30
references.pmid: 16453330
references.citation: Ann Surg. 2009 Feb;249(2):195-202
references.pmid: 19212170
references.citation: Hepat Mon. 2012 Aug;12(8):e6126
references.pmid: 23087749
references.citation: Hepatology. 2011 Sep 2;54(3):829-36
references.pmid: 21809355
references.citation: J Med Virol. 2003 Dec;71(4):492-8
references.pmid: 14556260
references.citation: Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):521-4
references.pmid: 22338173
references.citation: Hepatology. 2001 Dec;34(6):1225-41
references.pmid: 11732013
references.citation: J Viral Hepat. 2009 Jun;16(6):437-43
references.pmid: 19226331
references.citation: J Clin Virol. 2006 Feb;35(2):185-92
references.pmid: 16103008
references.citation: Int J Oncol. 2012 Sep;41(3):903-9
references.pmid: 22692851
references.citation: Clin Microbiol Rev. 2012 Jan;25(1):142-63
references.pmid: 22232374
references.citation: N Engl J Med. 2011 Sep 22;365(12):1118-27
references.pmid: 21992124
references.citation: Liver Int. 2012 Feb;32(2):231-40
references.pmid: 21745272
references.citation: Gut. 2000 Sep;47(3):429-35
references.pmid: 10940283
references.citation: World J Gastroenterol. 2007 Nov 21;13(43):5682-6
references.pmid: 17963292
references.citation: Gastroenterology. 2004 Jan;126(1):102-10
references.pmid: 14699492
references.citation: J Clin Virol. 2005 Dec;34 Suppl 1:S15-21
references.pmid: 16461218
references.citation: Semin Immunopathol. 2013 Jan;35(1):39-52
references.pmid: 22829332
references.citation: Lancet. 1993 Nov 27;342(8883):1340-4
references.pmid: 7694023
references.citation: J Med Virol. 2010 May;82(5):747-54
references.pmid: 20336715
references.citation: J Infect Dis. 2000 Jun;181(6):1920-8
references.pmid: 10837171
references.citation: N Engl J Med. 1997 Dec 11;337(24):1733-45
references.pmid: 9392700
references.citation: Hepatology. 2011 Aug;54(2):434-42
references.pmid: 21374690